Page 221 - Pagetit
P. 221

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE



                   Kikuchi-Yorioka Y, Sawaguchi T (2000) Parallel visuospatial and audiospatial
                   working memory processes in the monkey dorsolateral prefrontal cortex. Nature
                   Reviews in Neuroscience, 3:1075–1076.
                   Kilts CD et al. (2001) Neural activity related to drug craving in cocaine addiction.
                   Archives of General Psychiatry, 58:334–341.
                   Knable MB, Weinberger DR (1997) Dopamine, the prefrontal cortex and
                   schizophrenia. Journal of Psychopharmacology, 11:123–131.
                   Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward
                   pathways. Trends in Pharmacological Sciences, 13:177–184.
                   Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis.
                   Neuropsychopharmacology, 24:97–129.
                   Koob GF, Wall TL, Bloom FE (1989) Nucleus accumbens as a substrate for the
                   aversive stimulus effects of opiate withdrawal. Psychopharmacology, 98:530–534.
                   Koob GF et al. (1993) Opponent process and drug dependence: neurobiological
                   mechanisms. Seminars in Neuroscience, 5:351–358.
                   Kosten TR, Ziedonis DM (1997) Substance abuse and schizophrenia: editors’
                   introduction. Schizophrenia Bulletin, 23:181–186.
                   Kosten TR, Markou A, Koob GF (1998) Depression and stimulant dependence:
                   neurobiology and pharmacotherapy. Journal of Nervous and Mental Disorders,
                   186:737–745.
                   Krystal JH et al. (1999) Toward a rational pharmacotherapy of comorbid substance
                   abuse in schizophrenic patients. Schizophrenia Research, 35(Suppl.):S35–S49.
                   Lahti AC et al. (1995) Subanesthetic doses of ketamine stimulate psychosis in
                   schizophrenia. Neuropsychopharmacology, 13:9–19.
                   Lam RW et al. (1996) Effects of rapid tryptophan depletion in patients with
                   seasonal affective disorder in remission after light therapy. Archives of General
                   Psychiatry, 53:41–44.
                   Latimer WW et al. (2002) Gender differences in psychiatric comorbidity among
                   adolescents with substance use disorders. Experimental & Clinical Psycho-
                   pharmacology, 10:310-315.
                   Le Duc PA, Mittleman G (1995) Schizophrenia and psychostimulant abuse: a
                   review and re-analysis of clinical evidence. Psychopharmacology, 121:407–427.
                   Legault M, Rompre PP, Wise RA (2000) Chemical stimulation of the ventral
                   hippocampus elevates nucleus accumbens dopamine by activating dopaminergic
                   neurons of the ventral tegmental area. Journal of Neuroscience, 20:1635–1642.
                   Liljequist S (1991) NMDA receptor antagonists inhibit ethanol-produced
                   locomotor stimulation in NMRI mice. Alcohol, 8:309–312.
                   Lima L, Salazar M, Trejo E (1993) Modulation of 5-HTIA receptors in the
                   hippocampus and the raphe area of rats treated with clonazepam. Progress in
                   Neuropsychopharmacology and Biological Psychiatry, 17:663–677.
                   Lloyd KG, Thuret F, Pilc A (1985) Upregulation of gamma-aminobutyric acid
                   (GABA) B binding sites in rat frontal cortex: a common action of repeated
                   administration of different classes of antidepressants and electroshock. Journal
                   of Pharmacology and Experimental Therapeutics, 235:191–199.


                                                  200




          Chapter_6                200                             19.1.2004, 11:49
   216   217   218   219   220   221   222   223   224   225   226